GenFleet

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

Bluefin Biomedicine

This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.

genemedicine

This company develops oncolytic adenovirus therapies for cancer patients and provides drug delivery systems and manufacturing services to the biotechnology sector.

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.

Genespire

This company develops off-the-shelf gene therapies for children and adults affected by inherited metabolic diseases and primary immunodeficiencies.

Genome&Co

This company develops microbiome-based therapeutics and novel antibody drugs for pharmaceutical partners and patients with cancer or skin diseases.

LTZ Therapeutics

This biopharma company develops myeloid engager immunotherapies for patients with cancer and autoimmune diseases.